These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11564550)

  • 1. Colonic metabolism of ranitidine: implications for its delivery and absorption.
    Basit AW; Lacey LF
    Int J Pharm; 2001 Oct; 227(1-2):157-65. PubMed ID: 11564550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Susceptibility of the H2-receptor antagonists cimetidine, famotidine and nizatidine, to metabolism by the gastrointestinal microflora.
    Basit AW; Newton JM; Lacey LF
    Int J Pharm; 2002 Apr; 237(1-2):23-33. PubMed ID: 11955801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validated HPLC method for the determination of ranitidine in plasma.
    Castro A; Arancibia A; Romero P; Gai MN
    Pharmazie; 2003 Oct; 58(10):696-8. PubMed ID: 14609279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of prokinetic agents, cisapride and metoclopramide, on the bioavailability in humans and intestinal permeability in rats of ranitidine, and intestinal charcoal transit in rats.
    Lee HT; Lee YJ; Chung SJ; Shim CK
    Res Commun Mol Pathol Pharmacol; 2000; 108(5-6):311-23. PubMed ID: 11958284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of post-column fluorescence derivatization to develop a liquid chromatographic assay for ranitidine and its metabolites in biological fluids.
    Viñas P; Campillo N; López-Erroz C; Hernández-Córdoba M
    J Chromatogr B Biomed Sci Appl; 1997 Jun; 693(2):443-9. PubMed ID: 9210451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioavailability of ranitidine in healthy Mexican volunteers: effect of food.
    Juárez-Olguín H; Flores J; Pérez G; Hernández G; Flores C; Guillé A; Camacho A; Toledo A; Carrasco M; Lares I
    Proc West Pharmacol Soc; 2002; 45():156-8. PubMed ID: 12434565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of the InteliSite capsule to study ranitidine absorption from various sites within the human intestinal tract.
    Pithavala YK; Heizer WD; Parr AF; O'Connor-Semmes RL; Brouwer KL
    Pharm Res; 1998 Dec; 15(12):1869-75. PubMed ID: 9892471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solid-phase extraction and determination of ranitidine in human plasma by a high-performance liquid chromatographic method utilizing midbore chromatography.
    Farthing D; Brouwer KL; Fakhry I; Sica D
    J Chromatogr B Biomed Sci Appl; 1997 Jan; 688(2):350-3. PubMed ID: 9061475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simple and robust high-performance liquid chromatographic method for the determination of ranitidine in microvolumes of human serum.
    López-Calull C; García-Capdevila L; Arroyo C; Bonal J
    J Chromatogr B Biomed Sci Appl; 1997 May; 693(1):228-32. PubMed ID: 9200540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled delivery of ranitidine in the stomach using magnetic field.
    Saravanan M; Balaji AB; Kavitha P; Kingsley JD
    West Indian Med J; 2009 Mar; 58(2):87-91. PubMed ID: 21866590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic drug interaction study: administration of ceftibuten concurrently with the antacid mylanta double- strength liquid or with ranitidine.
    Radwanski E; Nomeir A; Cutler D; Affrime M; Lin CC
    Am J Ther; 1998 Mar; 5(2):67-72. PubMed ID: 10099040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of two compartmental models for describing ranitidine's plasmatic profiles.
    Schaiquevich P; Niselman A; Rubio M
    Pharmacol Res; 2002 May; 45(5):399-405. PubMed ID: 12123628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioavailability of a formulation containing a diclofenac-ranitidine combination.
    Carrasco-Portugal Mdel C; Aguilar-Cota ME; Pérez-Urizar J; Cabrera O; Herrera JE; Flores-Murrieta FJ
    Proc West Pharmacol Soc; 2002; 45():8-10. PubMed ID: 12434510
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of gastric emptying and entero-hepatic circulation on bioequivalence assessment of ranitidine.
    Chrenova J; Durisova M; Mircioiu C; Dedik L
    Methods Find Exp Clin Pharmacol; 2010; 32(6):413-9. PubMed ID: 20852750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous determination of ranitidine and its metabolites in human plasma and urine by high-performance liquid chromatography.
    Prueksaritanont T; Sittichai N; Prueksaritanont S; Vongsaroj R
    J Chromatogr; 1989 May; 490(1):175-85. PubMed ID: 2760148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oil-entrapped ranitidine HCl beads heal peptic ulcers via local and systemic mechanisms.
    Ismail S; El-Mahdy M; Abd Ellah NH; Abdelmalek DA
    Drug Dev Ind Pharm; 2019 Feb; 45(2):231-243. PubMed ID: 30260710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Qualitative and quantitative analysis of ranitidine and its metabolites by high-performance liquid chromatography-mass spectrometry.
    Lant MS; Martin LE; Oxford J
    J Chromatogr; 1985 Apr; 323(1):143-52. PubMed ID: 4008551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ranitidine disposition in patients with renal impairment.
    Meffin PJ; Grgurinovich N; Brooks PM; Miners JO; Cochran M; Stranks G
    Br J Clin Pharmacol; 1983 Dec; 16(6):731-4. PubMed ID: 6318787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of sodium acid pyrophosphate on ranitidine bioavailability and gastrointestinal transit time.
    Koch KM; Parr AF; Tomlinson JJ; Sandefer EP; Digenis GA; Donn KH; Powell JR
    Pharm Res; 1993 Jul; 10(7):1027-30. PubMed ID: 8397394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human drug absorption kinetics and comparison to Caco-2 monolayer permeabilities.
    Polli JE; Ginski MJ
    Pharm Res; 1998 Jan; 15(1):47-52. PubMed ID: 9487545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.